|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
multiple interactions increases expression |
ISO |
[Fingolimod Hydrochloride results in increased abundance of 27-hydroxycholesterol] which results in increased expression of ABCA1 mRNA; NPC1 protein affects the reaction [Fingolimod Hydrochloride results in increased expression of ABCA1 protein]; UVI 3003 inhibits the reaction [Fingolimod Hydrochloride results in increased expression of ABCA1 protein] Fingolimod Hydrochloride results in increased expression of ABCA1 mRNA; Fingolimod Hydrochloride results in increased expression of ABCA1 protein |
CTD |
PMID:20056921 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions |
ISO |
Fingolimod Hydrochloride inhibits the reaction [Paraquat results in increased expression of ACTA2 mRNA]; Fingolimod Hydrochloride inhibits the reaction [Paraquat results in increased expression of ACTA2 protein] |
CTD |
PMID:24893116 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Adm |
adrenomedullin |
multiple interactions |
EXP |
Fingolimod Hydrochloride promotes the reaction [Mercuric Chloride results in increased expression of ADM mRNA]; Fingolimod Hydrochloride promotes the reaction [Mercuric Chloride results in increased expression of ADM protein] |
CTD |
PMID:15680492 |
|
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions decreases phosphorylation |
ISO |
Acetylcysteine inhibits the reaction [Fingolimod Hydrochloride results in decreased phosphorylation of AKT1 protein]; pifithrin inhibits the reaction [Fingolimod Hydrochloride results in decreased phosphorylation of AKT1 protein]; pyrazolanthrone inhibits the reaction [Fingolimod Hydrochloride results in decreased phosphorylation of AKT1 protein] |
CTD |
PMID:25939952 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Apoa1 |
apolipoprotein A1 |
multiple interactions |
ISO |
Fingolimod Hydrochloride promotes the reaction [APOA1 protein results in increased secretion of Cholesterol] |
CTD |
PMID:20056921 |
|
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
Atg12 |
autophagy related 12 |
increases expression |
ISO |
Fingolimod Hydrochloride results in increased expression of ATG12 protein |
CTD |
PMID:25939952 |
|
NCBI chr18:39,452,247...39,462,424
Ensembl chr18:39,452,191...39,462,418
|
|
G |
Atg3 |
autophagy related 3 |
increases expression |
ISO |
Fingolimod Hydrochloride results in increased expression of ATG3 protein |
CTD |
PMID:25939952 |
|
NCBI chr11:55,624,914...55,653,249
Ensembl chr11:55,624,917...55,653,224
|
|
G |
Atg5 |
autophagy related 5 |
increases expression |
ISO |
Fingolimod Hydrochloride results in increased expression of ATG5 protein |
CTD |
PMID:25939952 |
|
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
|
|
G |
Atg7 |
autophagy related 7 |
increases expression |
ISO |
Fingolimod Hydrochloride results in increased expression of ATG7 protein |
CTD |
PMID:25939952 |
|
NCBI chr 4:147,718,663...147,925,656
Ensembl chr 4:147,718,752...147,925,593
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
ISO |
Fingolimod Hydrochloride results in decreased expression of BCL2 mRNA |
CTD |
PMID:28662296 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
increases expression |
ISO |
Fingolimod Hydrochloride results in increased expression of BDNF mRNA |
CTD |
PMID:24859201 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Becn1 |
beclin 1 |
multiple interactions |
ISO |
BECN1 mutant form inhibits the reaction [Fingolimod Hydrochloride results in increased cleavage of PARP1 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [Fingolimod Hydrochloride results in increased cleavage of BECN1 protein]; Fingolimod Hydrochloride results in increased expression of and results in increased cleavage of BECN1 protein |
CTD |
PMID:25939952 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases cleavage increases activity |
ISO |
3-methyladenine inhibits the reaction [Fingolimod Hydrochloride results in increased cleavage of CASP3 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [Fingolimod Hydrochloride results in increased cleavage of CASP3 protein] Fingolimod Hydrochloride results in increased activity of CASP3 protein |
CTD |
PMID:25939952 PMID:29654831 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases cleavage multiple interactions |
ISO |
Fingolimod Hydrochloride results in increased cleavage of CASP8 protein SQSTM1 mutant form inhibits the reaction [Fingolimod Hydrochloride results in increased cleavage of CASP8 protein] |
CTD |
PMID:25939952 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions increases expression increases response to substance |
ISO |
3-amino-4-(3-hexylphenylamino)-4-oxobutylphosphonic acid inhibits the reaction [Fingolimod Hydrochloride results in increased expression of CCL2 protein]; [lipopolysaccharide, Escherichia coli O111 B4 co-treated with Okadaic Acid co-treated with Fingolimod Hydrochloride] results in increased expression of and results in increased secretion of CCL2 protein CCL2 results in increased susceptibility to Fingolimod Hydrochloride |
CTD |
PMID:23043544 PMID:33069748 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression multiple interactions |
ISO |
Fingolimod Hydrochloride results in decreased expression of CCND1 mRNA Estradiol inhibits the reaction [Fingolimod Hydrochloride results in decreased expression of CCND1 mRNA]; Fingolimod Hydrochloride inhibits the reaction [Estradiol results in decreased expression of CCND1 mRNA] |
CTD |
PMID:29654831 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccng2 |
cyclin G2 |
increases expression |
ISO |
Fingolimod Hydrochloride results in increased expression of CCNG2 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
|
|
G |
Ccr4 |
C-C motif chemokine receptor 4 |
decreases expression |
ISO |
Fingolimod Hydrochloride results in decreased expression of CCR4 mRNA |
CTD |
PMID:28662296 |
|
NCBI chr 8:114,176,291...114,182,033
Ensembl chr 8:114,176,974...114,178,056
|
|
G |
Ccr7 |
C-C motif chemokine receptor 7 |
decreases expression |
ISO |
Fingolimod Hydrochloride results in decreased expression of CCR7 mRNA |
CTD |
PMID:28662296 |
|
NCBI chr10:84,098,193...84,108,309
Ensembl chr10:84,097,381...84,108,309
|
|
G |
Cd19 |
CD19 molecule |
decreases expression |
ISO |
Fingolimod Hydrochloride results in decreased expression of CD19 mRNA |
CTD |
PMID:28662296 |
|
NCBI chr 1:180,987,286...180,993,920
Ensembl chr 1:180,987,286...180,993,975
|
|
G |
Cd28 |
Cd28 molecule |
decreases expression |
ISO |
Fingolimod Hydrochloride results in decreased expression of CD28 mRNA |
CTD |
PMID:28662296 |
|
NCBI chr 9:62,166,324...62,194,674
Ensembl chr 9:62,166,192...62,194,685
|
|
G |
Cd3e |
CD3 epsilon subunit of T-cell receptor complex |
decreases expression |
ISO |
Fingolimod Hydrochloride results in decreased expression of CD3E mRNA |
CTD |
PMID:28662296 |
|
NCBI chr 8:45,303,848...45,315,005
Ensembl chr 8:45,303,852...45,315,022
|
|
G |
Cd40lg |
CD40 ligand |
decreases expression |
ISO |
Fingolimod Hydrochloride results in decreased expression of CD40LG mRNA |
CTD |
PMID:28662296 |
|
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
|
|
G |
Cd8a |
CD8 subunit alpha |
decreases expression |
ISO |
Fingolimod Hydrochloride results in decreased expression of CD8A mRNA |
CTD |
PMID:28662296 |
|
NCBI chr 4:103,365,804...103,370,041
Ensembl chr 4:103,365,804...103,370,040
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions |
ISO |
Fingolimod Hydrochloride inhibits the reaction [Paraquat results in increased expression of COL1A1 mRNA] |
CTD |
PMID:24893116 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
multiple interactions |
ISO |
Fingolimod Hydrochloride inhibits the reaction [Paraquat results in increased expression of COL3A1 mRNA] |
CTD |
PMID:24893116 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Comt |
catechol-O-methyltransferase |
increases expression |
ISO |
Fingolimod Hydrochloride results in increased expression of COMT mRNA |
CTD |
PMID:29654831 |
|
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
multiple interactions decreases expression |
ISO |
Fingolimod Hydrochloride inhibits the reaction [Estradiol results in increased expression of CXCR4 mRNA] Fingolimod Hydrochloride results in decreased expression of CXCR4 mRNA |
CTD |
PMID:29654831 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
decreases expression |
ISO |
Fingolimod Hydrochloride results in decreased expression of CYP19A1 mRNA |
CTD |
PMID:29654831 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
decreases expression |
ISO |
Fingolimod Hydrochloride results in decreased expression of CYP1A1 mRNA |
CTD |
PMID:29654831 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
decreases expression |
ISO |
Fingolimod Hydrochloride results in decreased expression of CYP1B1 mRNA |
CTD |
PMID:29654831 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
Fingolimod Hydrochloride inhibits the reaction [Estradiol results in increased expression of ESR1 protein] |
CTD |
PMID:29654831 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions decreases expression |
ISO |
Fingolimod Hydrochloride inhibits the reaction [Estradiol results in increased expression of ESR2 protein] Fingolimod Hydrochloride results in decreased expression of ESR2 protein |
CTD |
PMID:29654831 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Fas |
Fas cell surface death receptor |
multiple interactions |
ISO |
[lipopolysaccharide, Escherichia coli O111 B4 co-treated with Okadaic Acid co-treated with Fingolimod Hydrochloride] results in increased expression of FAS mRNA |
CTD |
PMID:33069748 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Fingolimod Hydrochloride results in increased expression of FOS mRNA |
CTD |
PMID:24859201 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Foxp3 |
forkhead box P3 |
decreases expression |
ISO |
Fingolimod Hydrochloride results in decreased expression of FOXP3 mRNA |
CTD |
PMID:28662296 |
|
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
|
|
G |
Gnaq |
G protein subunit alpha q |
multiple interactions |
ISO |
Fingolimod Hydrochloride inhibits the reaction [sphingosine 1-phosphate results in increased expression of GNAQ protein] |
CTD |
PMID:25980589 |
|
NCBI chr 1:213,425,631...213,671,947
Ensembl chr 1:213,424,465...213,667,672
|
|
G |
Hdac1 |
histone deacetylase 1 |
affects binding multiple interactions |
ISO |
Fingolimod Hydrochloride metabolite binds to HDAC1 protein Fingolimod Hydrochloride metabolite inhibits the reaction [S1PR1 protein binds to HDAC1 protein]; SPHK2 protein promotes the reaction [Fingolimod Hydrochloride metabolite binds to HDAC1 protein] |
CTD |
PMID:24859201 |
|
NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
increases expression |
ISO |
Fingolimod Hydrochloride results in increased expression of HMGCR mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
increases expression |
ISO |
Fingolimod Hydrochloride results in increased expression of HMGCS1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
|
|
G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
increases expression |
ISO |
Fingolimod Hydrochloride results in increased expression of IDI1 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
Fingolimod Hydrochloride inhibits the reaction [Paraquat results in increased expression of IL1B protein] |
CTD |
PMID:24893116 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
ISO |
[lipopolysaccharide, Escherichia coli O111 B4 co-treated with Okadaic Acid co-treated with Fingolimod Hydrochloride] results in decreased expression of and results in decreased secretion of IL4 protein |
CTD |
PMID:33069748 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
[lipopolysaccharide, Escherichia coli O111 B4 co-treated with Okadaic Acid co-treated with Fingolimod Hydrochloride] results in increased expression of and results in increased secretion of IL6 protein; Fingolimod Hydrochloride inhibits the reaction [Paraquat results in increased expression of IL6 protein] |
CTD |
PMID:24893116 PMID:33069748 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
decreases activity |
ISO |
Fingolimod Hydrochloride results in decreased activity of KCNH2 protein |
CTD |
PMID:25223691 |
|
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
|
|
G |
Klhl24 |
kelch-like family member 24 |
increases expression |
ISO |
Fingolimod Hydrochloride results in increased expression of KLHL24 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr11:80,843,621...80,877,649
Ensembl chr11:80,846,755...80,877,636
|
|
G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
multiple interactions |
ISO |
[lipopolysaccharide, Escherichia coli O111 B4 co-treated with Okadaic Acid co-treated with Fingolimod Hydrochloride] results in increased expression of MAP3K5 mRNA |
CTD |
PMID:33069748 |
|
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation |
ISO |
Fingolimod Hydrochloride results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:25939952 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation |
ISO |
Fingolimod Hydrochloride results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:25939952 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions |
ISO |
Fingolimod Hydrochloride inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP9 mRNA]; Fingolimod Hydrochloride inhibits the reaction [sphingosine 1-phosphate results in increased expression of MMP9 protein] |
CTD |
PMID:25980589 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
decreases phosphorylation |
ISO |
Fingolimod Hydrochloride results in decreased phosphorylation of MTOR protein |
CTD |
PMID:25939952 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Npc1 |
NPC intracellular cholesterol transporter 1 |
multiple interactions increases expression |
ISO |
NPC1 protein affects the reaction [Fingolimod Hydrochloride results in increased expression of ABCA1 protein] Fingolimod Hydrochloride results in increased expression of NPC1 protein |
CTD |
PMID:20056921 |
|
NCBI chr18:3,379,482...3,425,100
Ensembl chr18:3,379,482...3,425,049
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions increases cleavage |
ISO |
3-methyladenine inhibits the reaction [Fingolimod Hydrochloride results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Fingolimod Hydrochloride results in increased cleavage of PARP1 protein]; BECN1 mutant form inhibits the reaction [Fingolimod Hydrochloride results in increased cleavage of PARP1 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [Fingolimod Hydrochloride results in increased cleavage of PARP1 protein]; necrostatin-1 inhibits the reaction [Fingolimod Hydrochloride results in increased cleavage of PARP1 protein]; pifithrin inhibits the reaction [Fingolimod Hydrochloride results in increased cleavage of PARP1 protein]; pyrazolanthrone inhibits the reaction [Fingolimod Hydrochloride results in increased cleavage of PARP1 protein]; RIPK3 mutant form inhibits the reaction [Fingolimod Hydrochloride results in increased cleavage of PARP1 protein]; SQSTM1 mutant form inhibits the reaction [Fingolimod Hydrochloride results in increased cleavage of PARP1 protein] |
CTD |
PMID:25939952 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pdcd4 |
programmed cell death 4 |
increases expression |
ISO |
Fingolimod Hydrochloride results in increased expression of PDCD4 mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 1:252,921,342...252,944,278
Ensembl chr 1:252,921,392...252,944,275
|
|
G |
Plcb4 |
phospholipase C, beta 4 |
multiple interactions |
ISO |
Fingolimod Hydrochloride inhibits the reaction [sphingosine 1-phosphate results in increased expression of PLCB4 protein] |
CTD |
PMID:25980589 |
|
NCBI chr 3:122,952,965...123,322,522
Ensembl chr 3:122,953,196...123,322,392
|
|
G |
Ppp2ca |
protein phosphatase 2 catalytic subunit alpha |
multiple interactions |
ISO |
[lipopolysaccharide, Escherichia coli O111 B4 co-treated with Okadaic Acid co-treated with Fingolimod Hydrochloride co-treated with Memantine] results in increased expression of PPP2CA mRNA; [lipopolysaccharide, Escherichia coli O111 B4 co-treated with Okadaic Acid co-treated with Fingolimod Hydrochloride co-treated with Memantine] results in increased expression of PPP2CA protein; [lipopolysaccharide, Escherichia coli O111 B4 co-treated with Okadaic Acid co-treated with Fingolimod Hydrochloride] results in decreased expression of PPP2CA protein; [lipopolysaccharide, Escherichia coli O111 B4 co-treated with Okadaic Acid co-treated with Fingolimod Hydrochloride] results in increased expression of PPP2CA mRNA |
CTD |
PMID:33069748 |
|
NCBI chr10:36,358,110...36,377,864
Ensembl chr10:36,358,101...36,377,862
|
|
G |
Ripk1 |
receptor interacting serine/threonine kinase 1 |
multiple interactions increases expression |
ISO |
necrostatin-1 inhibits the reaction [Fingolimod Hydrochloride results in increased expression of RIPK1 protein] |
CTD |
PMID:25939952 |
|
NCBI chr17:30,839,639...30,871,824
Ensembl chr17:30,839,650...30,871,824
|
|
G |
Ripk3 |
receptor-interacting serine-threonine kinase 3 |
increases expression multiple interactions |
ISO |
Fingolimod Hydrochloride results in increased expression of RIPK3 protein RIPK3 mutant form inhibits the reaction [Fingolimod Hydrochloride results in increased cleavage of PARP1 protein]; RIPK3 mutant form inhibits the reaction [Fingolimod Hydrochloride results in increased phosphorylation of TP53 protein] |
CTD |
PMID:25939952 |
|
NCBI chr15:29,283,153...29,292,107
Ensembl chr15:29,283,145...29,292,121
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
decreases phosphorylation |
ISO |
Fingolimod Hydrochloride results in decreased phosphorylation of RPS6KB1 protein |
CTD |
PMID:25939952 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
multiple interactions decreases expression decreases activity |
ISO |
Fingolimod Hydrochloride inhibits the reaction [SPHK2 protein results in increased expression of S1PR1 protein]; Fingolimod Hydrochloride metabolite inhibits the reaction [S1PR1 protein binds to HDAC1 protein] [3-amino-4-(3-hexylphenylamino)-4-oxobutylphosphonic acid results in decreased activity of S1PR1 protein] which results in decreased susceptibility to Fingolimod Hydrochloride Fingolimod Hydrochloride results in decreased expression of S1PR1 protein Fingolimod Hydrochloride analog results in decreased activity of S1PR1 protein |
CTD |
PMID:23043544 PMID:24420784 PMID:24859201 |
|
NCBI chr 2:203,624,752...203,629,110
Ensembl chr 2:203,621,587...203,629,681
|
|
G |
S1pr3 |
sphingosine-1-phosphate receptor 3 |
multiple interactions |
ISO |
Fingolimod Hydrochloride inhibits the reaction [sphingosine 1-phosphate results in increased expression of S1PR3 protein] |
CTD |
PMID:25980589 |
|
NCBI chr17:13,781,050...13,794,408
Ensembl chr17:13,781,050...13,794,505
|
|
G |
Sphk2 |
sphingosine kinase 2 |
multiple interactions increases phosphorylation increases response to substance |
ISO |
Fingolimod Hydrochloride inhibits the reaction [SPHK2 protein results in increased expression of S1PR1 protein]; SPHK2 protein promotes the reaction [Fingolimod Hydrochloride metabolite binds to HDAC1 protein] SPHK2 protein results in increased phosphorylation of Fingolimod Hydrochloride SPHK2 results in increased susceptibility to Fingolimod Hydrochloride |
CTD |
PMID:23043544 PMID:24859201 |
|
NCBI chr 1:96,180,872...96,188,592
Ensembl chr 1:96,180,887...96,188,391
|
|
G |
Sqle |
squalene epoxidase |
increases expression |
ISO |
Fingolimod Hydrochloride results in increased expression of SQLE mRNA |
CTD |
PMID:24356939 |
|
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions decreases expression |
ISO |
Fingolimod Hydrochloride affects the reaction [bafilomycin A1 results in increased expression of SQSTM1 protein]; SQSTM1 mutant form inhibits the reaction [Fingolimod Hydrochloride results in increased cleavage of CASP8 protein]; SQSTM1 mutant form inhibits the reaction [Fingolimod Hydrochloride results in increased cleavage of PARP1 protein] Fingolimod Hydrochloride results in decreased expression of SQSTM1 protein |
CTD |
PMID:25939952 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
multiple interactions |
ISO |
[lipopolysaccharide, Escherichia coli O111 B4 co-treated with Okadaic Acid co-treated with Fingolimod Hydrochloride] results in increased expression of STAT1 protein modified form |
CTD |
PMID:33069748 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Tfe3 |
transcription factor binding to IGHM enhancer 3 |
decreases phosphorylation |
ISO |
Fingolimod Hydrochloride results in decreased phosphorylation of TFE3 protein |
CTD |
PMID:29945972 |
|
NCBI chr X:14,729,547...14,742,830
Ensembl chr X:14,729,550...14,742,571
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
ISO |
Fingolimod Hydrochloride inhibits the reaction [Paraquat results in increased expression of TGFB1 mRNA] |
CTD |
PMID:24893116 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
[lipopolysaccharide, Escherichia coli O111 B4 co-treated with Okadaic Acid co-treated with Fingolimod Hydrochloride] results in increased expression of and results in increased secretion of TNF protein; Fingolimod Hydrochloride inhibits the reaction [Paraquat results in increased expression of TNF protein] |
CTD |
PMID:24893116 PMID:33069748 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases phosphorylation |
ISO |
Acetylcysteine inhibits the reaction [Fingolimod Hydrochloride results in increased phosphorylation of TP53 protein]; necrostatin-1 inhibits the reaction [Fingolimod Hydrochloride results in increased phosphorylation of TP53 protein]; pyrazolanthrone inhibits the reaction [Fingolimod Hydrochloride results in increased phosphorylation of TP53 protein]; RIPK3 mutant form inhibits the reaction [Fingolimod Hydrochloride results in increased phosphorylation of TP53 protein] |
CTD |
PMID:25939952 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
ISO |
Fingolimod Hydrochloride inhibits the reaction [Paraquat results in increased expression of VEGFA mRNA] |
CTD |
PMID:24893116 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vegfd |
vascular endothelial growth factor D |
increases expression |
ISO |
Fingolimod Hydrochloride results in increased expression of VEGFD mRNA |
CTD |
PMID:24859201 |
|
NCBI chr X:30,073,122...30,108,413
Ensembl chr X:30,074,163...30,108,295
|
|